Abbott acquisition positive, says Wells Fargo After Abbott announced its plan to acquire Chile-based branded generic pharmaceutical company CFR, Wells Fargo thinks that CFR is a good fit for Abbott's EPD growth platform from a strategic perspective. The firm reports that the deal expands EPD's footprint in Latin America and is expected to add 7c to the company's EPS in 2015. The firm keeps an Outperform rating on Abbott.
News For ABT From The Last 14 Days
Check below for free stories on ABT the last two weeks.